Jeetinder Singh Mahal Jasper Therapeutics, Inc. (JSPR) insider trading activity

Jeetinder Singh Mahal is Chief Operating Officer of Jasper Therapeutics, Inc.. Currently has a direct ownership of 25,009 shares of JSPR, which is worth approximately $539,444. The most recent transaction as insider was on Dec 12, 2024, when has been sold 900 shares (Voting Common Stock) at a price of $22.11 per share, resulting in proceeds of $19,899. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K

0% 3M change

90.0% 12M change

Total Value Held $539,444

Jeetinder Singh Mahal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2024	SELL Open market or private sale	$19,899 $22.11 p/Share	900 Reduced 3.47%	25,009 Voting Common Stock
Dec 12 2024	BUY Exercise of conversion of derivative security	$6,390 $7.1 p/Share	900 Added 3.36%	25,909 Voting Common Stock
Sep 12 2024	SELL Open market or private sale	$19,107 $21.23 p/Share	900 Reduced 3.47%	25,009 Voting Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$6,390 $7.1 p/Share	900 Added 3.36%	25,909 Voting Common Stock
Jun 12 2024	SELL Open market or private sale	$21,744 $24.16 p/Share	900 Reduced 3.47%	25,009 Voting Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	$6,390 $7.1 p/Share	900 Added 3.36%	25,909 Voting Common Stock
Mar 12 2024	SELL Open market or private sale	$23,796 $26.44 p/Share	900 Reduced 3.47%	25,009 Voting Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$6,390 $7.1 p/Share	900 Added 3.36%	25,909 Voting Common Stock
Oct 12 2023	SELL Payment of exercise price or tax liability	$31,557 $0.85 p/Share	37,126 Reduced 12.93%	250,097 Voting Common Stock
Jun 13 2023	SELL Open market or private sale	$14,940 $1.66 p/Share	9,000 Reduced 3.04%	287,223 Voting Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	$6,390 $0.71 p/Share	9,000 Added 2.95%	296,223 Voting Common Stock
Apr 12 2023	SELL Payment of exercise price or tax liability	$54,203 $1.46 p/Share	37,126 Reduced 11.45%	287,223 Voting Common Stock
Oct 12 2022	BUY Grant, award, or other acquisition	-	214,722 Added 39.83%	324,349 Voting Common Stock

JSM

Jeetinder Singh Mahal

Chief Operating Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Value

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR

Account